Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation
Clinical trial NCT05571111 · WITHDRAWN
Trial details
- NCT number
- NCT05571111
- Sponsor
- Ferring Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-04
- Primary completion
- 2024-03-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.